KATHLEEN BOOK: Open Payments
NPI 1417555996 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 19 payments from 9 companies in 2025. Trend: 2023 $167 · 2024 $236 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $76 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 3 | $46 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: Cologuard Collection Kit, Rybelsus, NURTEC ODT, CAPLYTA, TRELEGY ELLIPTA, JARDIANCE, UBRELVY, Ozempic.
Industry payments across IN — which companies pay providers there.
